Morganella septicemia

Morganella septicemia refers to a severe, life-threatening bloodstream infection and systemic dysregulated inflammatory response caused by bacteria of the genus *Morganella*, most commonly *Morganella morganii* Pathophysiologically, microbial proliferation and endotoxin release into the circulatory system trigger systemic inflammation, hemodynamic instability, hypoperfusion, and risk of multiple organ dysfunction syndrome

Morganella septicemia refers to a severe, life-threatening bloodstream infection and systemic dysregulated inflammatory response caused by bacteria of the genus *Morganella*, most commonly *Morganella morganii*

This condition primarily affects hospitalized, immunocompromised, elderly, or postsurgical patients, frequently disseminating from localized primary foci such as complicated urinary tract infections, hepatobiliary disease, intra-abdominal infections, or infected surgical wounds

This condition primarily affects hospitalized, immunocompromised, elderly, or postsurgical patients, frequently disseminating from localized primary foci such as complicated urinary tract infections, hepatobiliary disease, intra-abdominal infections, or infected surgical wounds Pathophysiologically, microbial proliferation and endotoxin release into the circulatory system trigger systemic inflammation, hemodynamic instability, hypoperfusion, and risk of multiple organ dysfunction syndrome Clinic...

This condition primarily affects hospitalized, immunocompromised, elderly, or postsurgical patients, frequently disseminating from localized primary foci such as complicated urinary tract infections, hepatobiliary disease, intra-abdominal infections, or infected surgical wounds

This condition primarily affects hospitalized, immunocompromised, elderly, or postsurgical patients, frequently disseminating from localized primary foci such as complicated urinary tract infections, hepatobiliary disease, intra-abdominal infections, or infected surgical wounds Clinical management is often complicated by high mortality rates and the organism's intrinsic and inducible AmpC beta-lactamase production, conferring resistance to multiple early-generation beta-lactam antimicrobials

Clinical management is often complicated by high mortality rates and the organism's intrinsic and inducible AmpC beta-lactamase production, conferring resistance to multiple early-generation beta-lactam antimicrobials